Cargando…
How I treat NTRK gene fusion-positive cancers
NTRK fusions are found at low frequencies (commonly <1%) in a range of common tumour types and at high frequencies (up to or greater than 90%) in rare cancer types (secretory breast carcinoma, mammary analogue secretory carcinoma and infantile fibrosarcoma). The fusions typically occur in a mutua...
Autor principal: | Lassen, Ulrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890394/ https://www.ncbi.nlm.nih.gov/pubmed/31803506 http://dx.doi.org/10.1136/esmoopen-2019-000612 |
Ejemplares similares
-
Identifying patients with NTRK fusion cancer
por: Solomon, J P, et al.
Publicado: (2019) -
A review of NTRK fusions in cancer
por: Manea, Cristina Alexandra, et al.
Publicado: (2022) -
Real-World Experience of NTRK Fusion–Positive Thyroid Cancer
por: Park, Jong Chul, et al.
Publicado: (2022) -
How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
por: Ekman, Simon
Publicado: (2020) -
Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
por: Amatu, A, et al.
Publicado: (2019)